ARCHIVES

PV-10 Produces 51 Percent Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

Funding Opportunities (8-page issue).

May 23, 2003